Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers

Por Fitzgerald, Niamh, Angus, Kathryn, Elders, Andrew, de Andrade, Marisa, Raistrick, Duncan, Heather, Nick, McCambridge, Jim
Publicado no Addiction (2016)